Analysis of the safety and efficacy of bariatric surgery for elderly obese patients over 65 years old.

doi:10.3877/cma.j.issn.2095-9605.2020.04.001

Abstract

Abstract:

Objective

To explore the safety and short-term efficacy of bariatric surgery in obese patients over 65 years of age.

Methods

A retrospective study of 57 obese patients who underwent bariatric surgery in the Gastrointestinal Surgery Department of the Second Affiliated Hospital of Anhui Medical University from January 2018 to February 2020 were divided into elderly group (age≥65 years old) and Non-elderly group (18 years old≤age<65 years old). Collect baseline data of all patients, postoperative complications, body weight, body mass index (BMI), fasting blood glucose (FPG), 2 hours postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c) before, 1, 3 and 6 months after surgery ), comorbidities and other indicators.

Results

A total of 57 obese patients with diabetes were included, including 17 in the elderly group and 40 in the non-elderly group. There were no significant differences in body weight, BMI, FPG, 2hPG, HbA1c complications, and postoperative complications between the two groups before and 3 months after surgery (P>0.05). The weight, BMI, FPG, 2hPG and other indicators of the elderly group and non-elderly group were significantly improved in the first, third, sisth months after the operation (P<0.05).

Conclusions

Bariatric surgery may be a safe and effective treatment for obese patients over 65 years old. Therefore, this study will bring new discussions on the age limitation of bariatric surgery.

Key words: Bariatric Surgery, Elderly, Obesity, Hypertension, Complication

Feng Cao, Yanyan Xu, Gang Yu, Yunsheng Cheng, Benli Jia, Yong Wang. Analysis of the safety and efficacy of bariatric surgery for elderly obese patients over 65 years old.[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2020, 06(04): 213-217.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2020.04.001

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2020/V06/I04/213

Figures/Tables 5

References 21

[1]	Hales CM, Fryar CD, Carroll MD, et al. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016[J]. The Journal of the American Medical Association, 2018, 319(16): 1723-1725.
[2]	Luchsinger JA, Gustafson DR. Adiposity and Alzheimer's disease[J]. Curr Opin Clin Nutr Metab Care, 2009, 12(1): 15-21.
[3]	Castagneto GL, Casella MJ, Genco A, et al. 10-year follow-up after laparoscopic sleeve gastrectomy: Outcomes in a monocentric series[J]. Surg Obes Relat Dis. 2018, 14(10): 1480-1487.
[4]	Nor HZ, Punchai S, Karas LA, et al. The outcome of bariatric surgery in patients aged 75 years and older[J]. Obes Surg, 2018, 28(6): 1498-1503.
[5]	Sung H, Siegel RL, Torre LA, et al. Global patterns in excess body weight and the associated cancer burden[J]. CA Cancer J Clin, 2019, 69(2): 88-112.
[6]	Susmallian S, Raziel A, Barnea R, et al. Bariatric surgery in older adults: Should there be an age limit?[J]. Medicine (Baltimore), 2019, 98(3): e13824.
[7]	Domienik-Karłowicz J, Ziemiański P, Małkowski P, et al. A Retrospective Study of 6-Month Reduction in Risk of Developing Cardiovascular Diseases and Type 2 Diabetes Mellitus in Severely Obese Patients Over 60 Years of Age Following Bariatric Surgery[J]. Med Sci Monit, 2019, 25: 2577-2582.
[8]	Parmar C, Mahawar KK, Carr WRJ, et al. Bariatric surgery in septuagenarians: a comparison with<60 year olds[J]. Obes Surg, 2017, 27(12): 3165-3169.
[9]	Ramirez A, Roy M, Hidalgo JE, et al. Outcomes of bariatric surgery in patients> 70 years old[J]. Surg Obes Relat Dis, 2012, 8(4): 458-462.
[10]	Willkomm CM, Fisher TL, Barnes GS, et al. Surgical weight loss>65 years old: is it worth the risk?[J]. Surg Obes Relat Dis, 2010, 6(5): 491-496.
[11]	Gonzalez-Heredia R, Patel N, Sanchez-Johnsen L, et al. Does age influence bariatric surgery outcomes?[J]. Bariatr Surg Pract Patient Care, 2015, 10(2): 74-78.
[12]	Giordano S, Victorzon M. Laparoscopic Roux-en-Y gastric bypass is effective and safe in over 55-year-old patients: a comparative analysis[J]. World J Surg, 2014, 38(5): 1121-1126.
[13]	Cazzo E, Gestic MA, Utrini MP, et al. Bariatric surgery in the elderly: A narrative review[J]. Rev Assoc Med Bras (1992), 2017, 63(9): 787-792.
[14]	Elbahrawy A, Bougie A, Loiselle SE, et al. Medium to long-term outcomes of bariatric surgery in older adults with super obesity[J]. Surg Obes Relat Dis, 2018, 14(4): 470-476.
[15]	Giordano S, Victorzon M. Bariatric surgery in elderly patients: a systematic review[J]. Clin Interv Aging, 2015, 10: 1627-1635.
[16]	Quebbemann B, Engstrom D. Bariatric surgery in patients older than 65 years is safe and effective[J]. Surg Obes Relat Dis, 2005, 1: 389-393.
[17]	Nelson LG, Lopez PP, Haines K, et al. Outcomes of bariatric surgery in patients ≥65 years[J]. Surg Obes Relat Dis, 2006, 2(3): 384-388.
[18]	Flum DR, Salem L, Elrod JA, et al. Early mortality among medicare beneficiaries undergoing bariatric surgical procedures[J]. The Journal of the American Medical Association, 2005, 294(15): 1903-1908.
[19]	Livingston EH, Langert J. The impact of age and medicare status on bariatric surgical outcomes[J]. Arch Surg. 2006, 141(11): 1115-1120, 1121.
[20]	O'Keefe KL, Kemmeter PR, Kemmeter KD. Bariatric surgery outcomes in patients aged 65 years and older at an American society for metabolic and bariatric surgery center of excellence[J]. Obes Surg, 2010, 20(9): 1199-1205.
[21]	Gebhart A, Young MT, Nguyen NT. Bariatric surgery in the elderly: 2009-2013[J]. Surg Obes Relat Dis, 2015, 11(2): 393-398.

变量	老年组	非老年组	t/χ²值	P值
性别			-	1.000^a
男（人）	4	11
女（人）	13	29
体重（kg）	142.24±13.85	140.65±11.75	0.443	0.660
BMI（kg/m²）	45.41±8.46	43.48±11.554	0.622	0.537
FPG（mmol/L）	11.13±2.01	10.86±2.26	0.429	0.669
2hPG（mmol/L）	17.24±4.94	16.29±2.32	0.769	0.451
HbA1c（%）	7.91±1.72	7.62±1.05	0.630	0.535
C肽（ng/mL）	3.45±1.69	3.73±0.98	-0.647	0.525
尿酸（mmol/L）	470.33±16.98	456.65±23.76	2.237	0.20
TG（mmol/L）	4.83±1.32	5.19±1.71	-0.768	0.446
合并症
高血压（人/%）	13/76.47	34/85	-	0.464^a
高血脂（人/%）	15/88.23	37/92.5	-	0.629^a
脂肪肝（人/%）	11/64.71	31/77.5	-	0.341^a
骨关节炎（人/%）	9/52.94	29/72.5	2.365	0.124
OSA（人/%）	12/70.59	31/77.5	-	0.738^a

变量	老年组	非老年组	t/χ²值	P值
性别			-	1.000^a
男（人）	4	11
女（人）	13	29
体重（kg）	142.24±13.85	140.65±11.75	0.443	0.660
BMI（kg/m²）	45.41±8.46	43.48±11.554	0.622	0.537
FPG（mmol/L）	11.13±2.01	10.86±2.26	0.429	0.669
2hPG（mmol/L）	17.24±4.94	16.29±2.32	0.769	0.451
HbA1c（%）	7.91±1.72	7.62±1.05	0.630	0.535
C肽（ng/mL）	3.45±1.69	3.73±0.98	-0.647	0.525
尿酸（mmol/L）	470.33±16.98	456.65±23.76	2.237	0.20
TG（mmol/L）	4.83±1.32	5.19±1.71	-0.768	0.446
合并症
高血压（人/%）	13/76.47	34/85	-	0.464^a
高血脂（人/%）	15/88.23	37/92.5	-	0.629^a
脂肪肝（人/%）	11/64.71	31/77.5	-	0.341^a
骨关节炎（人/%）	9/52.94	29/72.5	2.365	0.124
OSA（人/%）	12/70.59	31/77.5	-	0.738^a

变量	老年组	非老年组	t/χ²值	P值
体重（kg）	109.65±7.88	107.13±7.61	1.129	0.264
BMI（kg/m²）	26.55±5.71	28.02±6.38	-0.821	0.415
FPG（mmol/L）	5.12±0.99	5.04±1.56	0.265	0.792
2hPG（mmol/L）	9.18±1.37	9.11±2.00	0.123	0.903
C肽（ng/ml）	3.94±1.02	4.18±0.93	-0.88	0.383
尿酸（mmol/L）	387.65±19.28	369.27±21.06	1.947	0.517
TG（mmol/L）	2.98±0.73	2.79±1.14	0.831	0.607
合并症
高血压（人/%）	3 (76.9)	8 (76.5)	-	1.000^a
高血脂（人/%）	4 (73.3)	9 (75.7)		1.000^a
脂肪肝（人/%）	3 (72.7)	8 (74.2)		1.000^a
骨关节炎（人/%）	3 (66.7)	9 (69.0)		1.000^a
OSA（人/%）	2 (83.3)	5 (83.9)		1.000^a

变量	老年组	非老年组	t/χ²值	P值
体重（kg）	109.65±7.88	107.13±7.61	1.129	0.264
BMI（kg/m²）	26.55±5.71	28.02±6.38	-0.821	0.415
FPG（mmol/L）	5.12±0.99	5.04±1.56	0.265	0.792
2hPG（mmol/L）	9.18±1.37	9.11±2.00	0.123	0.903
C肽（ng/ml）	3.94±1.02	4.18±0.93	-0.88	0.383
尿酸（mmol/L）	387.65±19.28	369.27±21.06	1.947	0.517
TG（mmol/L）	2.98±0.73	2.79±1.14	0.831	0.607
合并症
高血压（人/%）	3 (76.9)	8 (76.5)	-	1.000^a
高血脂（人/%）	4 (73.3)	9 (75.7)		1.000^a
脂肪肝（人/%）	3 (72.7)	8 (74.2)		1.000^a
骨关节炎（人/%）	3 (66.7)	9 (69.0)		1.000^a
OSA（人/%）	2 (83.3)	5 (83.9)		1.000^a

变量	术前	术后1月	术后3月	术后6月	F值
体重（kg）	142.24±13.85	119.44±8.74	109.65±7.88	95.43±9.14	37.819
BMI（kg/m²）	45.41±8.46	34.97±0.87	26.55±5.71	24.10±4.33	38.070
FPG（mmol/L）	11.13±2.01	5.83±2.11	5.12±0.99	4.67±1.04	55.592
2hPG（mmol/L）	17.24±4.94	10.97±1.64	9.18±1.37	8.36±0.97	36.652

Please choose a citation manager

Content to export